“…9) The assessment for the prognostication should be multimodal and delayed until at least 72 hours after cardiac arrest. 10) Many unanswered questions remain regarding the ideal evaluation of TTM in pediatric neurocritical care, such as different durations and cooling depths, earlier TTM onset, and adjunctive neuroprotective agents. Physicians must recognize that the prognostic factors should be monitored during the first 3 phases of pediatric post-cardiac arrest and consider the appropriate therapeutic intervention to provide potential neuroprotection.…”